Literature DB >> 11287980

Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

J M Goldman, J V Melo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287980     DOI: 10.1056/NEJM200104053441409

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  49 in total

1.  Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).

Authors:  Hagop M Kantarjian; Neil P Shah; Jorge E Cortes; Michele Baccarani; Mohan B Agarwal; María Soledad Undurraga; Jianxiang Wang; Juan Julio Kassack Ipiña; Dong-Wook Kim; Michinori Ogura; Carolina Pavlovsky; Christian Junghanss; Jorge H Milone; Franck E Nicolini; Tadeusz Robak; Jan Van Droogenbroeck; Edo Vellenga; M Brigid Bradley-Garelik; Chao Zhu; Andreas Hochhaus
Journal:  Blood       Date:  2011-12-09       Impact factor: 22.113

Review 2.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

Review 3.  New therapeutic approach for myeloid leukemia: induction of apoptosis via modulation of reactive oxygen species production by natural compounds.

Authors:  Masahiro Kizaki
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

Review 4.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

Review 5.  Clinical uses of interferons.

Authors:  Robert M Friedman
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

Review 6.  Side-effects of protein kinase inhibitors on ion channels.

Authors:  Youn Kyoung Son; Hongzoo Park; Amy L Firth; Won Sun Park
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

7.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

Authors:  G H Fisher; S L Wellen; D Klimstra; J M Lenczowski; J W Tichelaar; M J Lizak; J A Whitsett; A Koretsky; H E Varmus
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

8.  Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.

Authors:  Alice Giustacchini; Supat Thongjuea; Nikolaos Barkas; Petter S Woll; Benjamin J Povinelli; Christopher A G Booth; Paul Sopp; Ruggiero Norfo; Alba Rodriguez-Meira; Neil Ashley; Lauren Jamieson; Paresh Vyas; Kristina Anderson; Åsa Segerstolpe; Hong Qian; Ulla Olsson-Strömberg; Satu Mustjoki; Rickard Sandberg; Sten Eirik W Jacobsen; Adam J Mead
Journal:  Nat Med       Date:  2017-05-15       Impact factor: 53.440

9.  Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway.

Authors:  Yan-jun Zhang; Cheng-rong Lu; Yan Cao; Yuan Luo; Rong-feng Bao; Shu Yan; Mei Xue; Feng Zhu; Zhe Wang; Lian-ning Duan
Journal:  Acta Pharmacol Sin       Date:  2012-03-05       Impact factor: 6.150

Review 10.  Advances in Targeting RET-Dependent Cancers.

Authors:  Vivek Subbiah; Gilbert J Cote
Journal:  Cancer Discov       Date:  2020-02-24       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.